XML 29 R19.htm IDEA: XBRL DOCUMENT v3.22.2.2
Stockholders' Equity (Tables)
9 Months Ended
Sep. 30, 2022
Class Of Stock [Line Items]  
Schedule of Stock-Based Compensation Expense Recognized

Total stock-based compensation expense was recognized in our condensed consolidated statements of operations and comprehensive loss as follows (in thousands):

 

 

 

For the Three Months
Ended September 30,

 

 

For the Nine Months
Ended September 30,

 

 

 

2022

 

 

2021

 

 

2022

 

 

2021

 

Research and development

 

$

873

 

 

$

872

 

 

$

2,677

 

 

$

2,342

 

General and administrative

 

 

1,312

 

 

 

1,171

 

 

 

4,002

 

 

 

3,509

 

Total stock-based compensation

 

$

2,185

 

 

$

2,043

 

 

$

6,679

 

 

$

5,851

 

 

Common Stock Warrants [Member]  
Class Of Stock [Line Items]  
Schedule of Warrant Activity

As of September 30, 2022, there were 1,145,631 warrants exercisable into common stock (after rounding for fractional shares and subject to beneficial ownership blockers).

 

 

 

Roll Forward of Warrant Activity

 

 

 

Registered direct
warrants, placement agent

 

 

Private placement warrants

 

 

Private placement warrants, placement agent

 

 

Warrants exchanged for common stock

 

 

Warrants exchanged for Series X1 preferred stock

 

 

Total

 

Balance as of December 31, 2021

 

 

9,581

 

 

 

319,064

 

 

 

9,177

 

 

 

509,117

 

 

 

298,692

 

 

 

1,145,631

 

Issued

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Exercised

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Cancelled/Expired

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Balance as of September 30, 2022

 

 

9,581

 

 

 

319,064

 

 

 

9,177

 

 

 

509,117

 

 

 

298,692

 

 

 

1,145,631

 

Preferred Stock Warrants [Member]  
Class Of Stock [Line Items]  
Schedule of Warrant Activity

As of September 30, 2022, there were 50,207.419 warrants exercisable into Series X1 Preferred Stock, which are convertible into 2,789,301 shares of common stock (after rounding for fractional shares and subject to beneficial ownership conversion blockers).

 

 

 

Roll Forward of
Series X
1
Convertible
Preferred
Warrant
Activity

 

 

 

Total

 

Balance as of December 31, 2021

 

 

50,207.419

 

Assumed and replaced

 

 

 

Exercised

 

 

 

Cancelled/Expired

 

 

 

Balance as of September 30, 2022

 

 

50,207.419